[{"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204519"], "brand_name": ["CELECOXIB"], "generic_name": ["CELECOXIB"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-168", "50268-169"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CELECOXIB"], "rxcui": ["205322", "205323"], "spl_id": ["de5b2d20-dbdf-3fd3-e053-2995a90a0de4"], "spl_set_id": ["951df0f7-5fb7-40f5-e053-2995a90a1edd"], "package_ndc": ["50268-168-11", "50268-168-15", "50268-169-11", "50268-169-15"], "original_packager_product_ndc": ["62332-141", "62332-142"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["JCX84Q7J1L"]}, "product_type": "Drugs", "event_id": "96888", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0460-2025", "product_description": "Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478.  NDC 50268-169-15", "product_quantity": "3,817 50-count cartons", "reason_for_recall": "Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules", "recall_initiation_date": "20250513", "center_classification_date": "20250609", "report_date": "20250618", "code_info": "Lot #47881, Exp 05/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66403", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-66403-005", "product_description": "Amlodipine Besylate Tablets, USP, 5 mg, packaged in a) 90-count bottles (NDC 0378-5209-77) and b) 500-count bottles (NDC 0378-5209-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "167,866 bottles", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.", "recall_initiation_date": "20130913", "center_classification_date": "20131104", "termination_date": "20150723", "report_date": "20131113", "code_info": "Lot s: a) 3036490, 3036491, 3036492, 3039874; b) 3036493, 3036494, 3039872, 3039873, 3041476, 3041477, 3044555, 3044683"}, {"status": "Ongoing", "city": "Rafelbunol", "state": "N/A", "country": "Spain", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73574", "recalling_firm": "Sesderma, SL", "address_1": "Calle Massamagrell 3-5", "address_2": "Poligono Industrial Rafelbunol", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed to following states: FL, PR, CO, GA.", "recall_number": "D-0845-2016", "product_description": "Repaskin 30 (octacrylene 4%, oxybenzone 3%, octisalate 3%, octinoxate 3% Avobenzone 3%) Body Lotion Sunscreen gel cream, Broad Spectrum SPF 30, 6.8 fl oz (200 mL) tube, over the counter,  Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0012-1 UPC8 429979 415691", "product_quantity": "20 bottles", "reason_for_recall": "cGMP Deviations; product does not comply with cGMP requirements", "recall_initiation_date": "20151015", "center_classification_date": "20160510", "report_date": "20160518", "code_info": "Lot code 41274901, exp 2/19."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-604-2015", "product_description": "Cyanocobalamin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "8489 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Moon Township", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["SENSODYNE"], "generic_name": ["STANNOUS FLUORIDE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0135-0547", "0135-0548", "0135-0575"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["STANNOUS FLUORIDE"], "rxcui": ["416784"], "spl_id": ["1309c3eb-8c5c-c532-e063-6394a90a5529"], "spl_set_id": ["34260c69-d829-46c0-b12a-5136ee073ba1"], "package_ndc": ["0135-0548-02", "0135-0548-01", "0135-0547-02", "0135-0575-01"], "is_original_packager": [true], "unii": ["3FTR44B32Q"]}, "product_type": "Drugs", "event_id": "71750", "recalling_firm": "GlaxoSmithkline Consmer Healthcare", "address_1": "1000 GSK Drive", "address_2": "N/A", "postal_code": "15108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico & Taiwan", "recall_number": "D-1324-2015", "product_description": "SENSODYNE WITH FLUORIDE REPAIR & PROTECT, a) 0.8 oz.(23 g) tubes, (NDC 0135-0548-01);  b) 3.4 oz. (96.4 g) tubes, (NDC 0135-0548-02) Manufactured by Oratech, South Jordan, UTAH 84095, Distributed by GlaxoSmithKline, Consumer Healthcare, L.P., Moon Township, PA 15108", "product_quantity": "325,504 tubes", "reason_for_recall": "Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush.", "recall_initiation_date": "20150715", "center_classification_date": "20150811", "termination_date": "20170419", "report_date": "20150819", "code_info": "Lot #     a)     R3J181, Exp 08/15   R4A191, R4A192, R41291, R4B011, Exp 12/15  R4C111, Exp 02/16     Lot # b)    R3G291, R3H011, Exp 06/15  R3H191, R3H261, R3H291, Exp 07/15  R3J171, R3J182, R3J191, R3J241, Exp 08/15  R3K031, R3K121, R3K221, R3K291, Exp 09/15  R3M111, R3M181, Exp 10/15  R3N081, R3N101, Exp 11/15  R4A211, Exp 12/15  R4B281, Exp 01/16  R4C041, R4C291, R4D021, Exp 02/16  R4D081, Exp 03/16  R4E231, Exp 04/16  R4F081, Exp 05/16  R4G191, Exp 06/16  R4H031, R4H071, R4H271, Exp 07/16"}, {"status": "Terminated", "city": "Boothwyn", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65180", "recalling_firm": "Pentec Health", "address_1": "4 Creek Pkwy Ste A", "address_2": "N/A", "postal_code": "19061-3132", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dialysis Centers  Direct to patient", "recall_number": "D-585-2013", "product_description": "IDPN (Intradialytic Parenteral Nutrition - dialysate solution with added amino acids), a) 490mL bag, b) 500mL bag, and c) 590mL bag, Pentec Health Inc., 4 Creek Parkway Suite A, Boothwyn, PA  19061-3132", "product_quantity": "3 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.", "recall_initiation_date": "20130515", "center_classification_date": "20130606", "termination_date": "20141216", "report_date": "20130612", "code_info": "Compounding Date: a) 04/25/13, b) 04/24/13    Discard After: a) 05/20/13, b) and c) 05/15/13"}, {"status": "Ongoing", "city": "Chestnut Ridge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076744"], "brand_name": ["TESTOSTERONE"], "generic_name": ["TESTOSTERONE"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-151", "64380-152"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["TESTOSTERONE"], "rxcui": ["1597123", "1597129"], "spl_id": ["6d50f17e-4607-458a-882b-620daa3b58a9"], "spl_set_id": ["ee54c393-bcfe-4a52-b7b3-1da8750f35d9"], "package_ndc": ["64380-152-01", "64380-152-02", "64380-151-01", "64380-151-02"], "is_original_packager": [true], "upc": ["0364380151012", "0364380152019"], "nui": ["N0000175824", "N0000000146", "M0001109"], "pharm_class_epc": ["Androgen [EPC]"], "pharm_class_moa": ["Androgen Receptor Agonists [MoA]"], "pharm_class_cs": ["Androstanes [CS]"], "unii": ["3XMK78S47O"]}, "product_type": "Drugs", "event_id": "96412", "recalling_firm": "Strides Pharma, Inc.", "address_1": "1 Ram Ridge Rd", "address_2": "N/A", "postal_code": "10977-6714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0294-2025", "product_description": "Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-152-02", "product_quantity": "244,412 Cartons; 30 sachets /Carton", "reason_for_recall": "Presence of foreign substance: Presence of Benzene.", "recall_initiation_date": "20250305", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot #: 5501103A, Exp Mar-25; 5501237A, 5501238A, Exp Apr-25; 5501278A, Exp May-25; 5501280A, 5501342A, Exp Jun-25; 5501372A, Exp Jul-25; 5501496A, Exp Aug-25; 5501499A, Exp Sep-25; 5501580A, Exp Oct-25; 5501582A, Exp Dec-25; 5501653A, 5501656A, Exp Jan-26; 5501770A, Exp Feb-26; 5501842A, 5501868A, 5501882A, Exp Apr-26; 5501957A, Exp May-26; 5502001A, Exp Jul-26; 5502033A, Exp Aug-26; 5502112A, 5502115A, Exp Oct-26; 5502180A, 5502181A, Exp Nov-26."}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0372-2016", "product_description": "Piracetam Injection, 200mg/mL,10mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "28 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0551-2019", "product_description": "Dr. King's Natural Medicine Homeopathic EMF Detox, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955597520, NDC 57955-5975-2", "product_quantity": "556 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 032816E Exp. 03/19; 033116M Exp. 03/19; 062817A Exp. 06/19"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "24 units", "code_info": "Rx # 28288, Exp 02/4/14; Rx # 29176, Exp 05/21/14; Rx # 28829, Exp 05/17/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cefepime 2 gm/100 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28288, Discard After 02/4/14; Rx # 29176, Discard After 05/21/14; Rx # 28829, Discard After 05/17/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1457-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Corona", "address_1": "132 Business Center Dr", "reason_for_recall": "Failed Tablet/Capsule Specifications; Product contains broken tablets.", "address_2": "", "product_quantity": "717 bottles", "code_info": "Lot #: 697316A, Expiry: Mar 2015.", "center_classification_date": "20140130", "distribution_pattern": "Nationally in: AZ, CA, CT, FL, NV, OH, OK, PA, SC, WI.", "state": "CA", "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only.  Manufactured by Watson Laboratories, Inc., Corona, CA 92880.  Distributed by: Watson Pharma, Inc. NDC: 00591-0517-01.", "report_date": "20140205", "classification": "Class II", "openfda": {}, "recalling_firm": "Watson Laboratories Inc", "recall_number": "D-1053-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67348", "termination_date": "20140725", "more_code_info": "", "recall_initiation_date": "20140115", "postal_code": "92880-1724", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82564", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AZ, CO", "recall_number": "D-1122-2019", "product_description": "Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablets,  Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478 --- NDC 42291-795-30", "product_quantity": "397 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)", "recall_initiation_date": "20190403", "center_classification_date": "20190411", "termination_date": "20200507", "report_date": "20190417", "code_info": "Lots: 201916 Exp. 08/2019; 20092 Exp. 08/2019"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1387-2022", "product_description": "AD PREV OINT ORIG 4 OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 900018", "more_code_info": ""}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["POLYVINYL ALCOHOL"], "generic_name": ["POLYVINYL ALCOHOL"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-678"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYVINYL ALCOHOL"], "rxcui": ["142004"], "spl_id": ["334b3c0f-7061-b4b8-e063-6394a90aee9a"], "spl_set_id": ["f18b61da-4033-341a-e053-2a95a90a8ebf"], "package_ndc": ["50268-678-15"], "is_original_packager": [true], "unii": ["532B59J990"]}, "product_type": "Drugs", "event_id": "96741", "recalling_firm": "BRS Analytical Services, LLC", "address_1": "11697 Lakeside Crossing Ct", "address_2": "N/A", "postal_code": "63146-8606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0408-2025", "product_description": "Polyvinyl Alcohol Ophthalmic Solution 1.4%, Lubricant Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-678-15.", "product_quantity": "14,333 cases (24 cartons per case)", "reason_for_recall": "cGMP deviations and lack of assurance of sterility.", "recall_initiation_date": "20250423", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot, expiry:  Lot 120, exp 10/02/25; Lot 122, exp 10/09/25; Lot 123, exp 10/12/25; Lot 124, exp 10/16/25; Lot 138, exp 1/08/26; Lot 142, exp 1/29/26; Lot 143, exp 2/01/26; Lot 144, exp 2/07/26; Lot 145, exp 2/12/26; Lot 146, exp 2/15/26; Lot 147, exp 2/21/26; Lot 148, exp 2/27/26; Lot 149, exp 3/04/26; Lot 150, exp 3/11/26; Lot 158, exp 4/15/26; Lot 159, exp 4/22/26; Lot 176, exp 7/24/26; Lot 177, exp 7/28/26; Lot 178, exp 7/31/26; Lot 179, exp 8/05/26.", "more_code_info": ""}, {"status": "Terminated", "city": "Worcester", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86717", "recalling_firm": "Lohxa LLC", "address_1": "600 Main St Ste 110", "address_2": "N/A", "postal_code": "01608-2061", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to medical facilities in FL and NY.", "recall_number": "D-0111-2021", "product_description": "Chlorhexidine Gluconate Oral Rinse USP, 0.12%, Alcohol Free, packaged in 15 mL unit does cups (barcode 7016602715), packaged in 50-count unit dose cups per carton, Rx only, Distributed by: Lohxa, Worcester, MA 01608, NDC 70166-027-15", "product_quantity": "329 cartons", "reason_for_recall": "Microbial contamination of non-sterile products: Repackaged product was recalled by manufacturer because it was contaminated with the bacteria Burkholderia lata.", "recall_initiation_date": "20201028", "center_classification_date": "20201130", "termination_date": "20220315", "report_date": "20201209", "code_info": "Lot #: T09101A, Exp 01/2021; T08292A, T10011A, Exp 02/2021; T10223A, M10193A, Exp 03/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92239", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distrituded to three direct account in PA.", "recall_number": "D-0577-2023", "product_description": "Ketotifen Fumarate 0.025 %, Antihistamine eye drops, 5mL bottle, MFG: Akorn, Lake Forrest IL 60045, Repackaged by: RemedyRepack Inc., Indiana, PA 15701,   NDC 70518-1142-00; Source NDC # 17477-0717-10;", "product_quantity": "12 5mL bottles", "reason_for_recall": "CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.", "recall_initiation_date": "20230501", "center_classification_date": "20230516", "report_date": "20230524", "code_info": "Lot # B1643789-041022, EXP 03/31/2024; B1894150-100722, B1891573-100622,  EXP. 7/31/2024"}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "unknown", "code_info": "all lot codes, .25 oz and 2 oz sizes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Calm & Correct Cream in 2 oz. containers with SKU number DM1020.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1488-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs:  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 11845014882, Pedigree: AD70700_7, EXP: 5/29/2014;  TACROLIMUS, Capsule, 0.5 mg, NDC 00781210201, Pedigree: W003169, EXP: 6/13/2014;  LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: AD42584_1, EXP: 5/14/2014.", "address_2": "", "product_quantity": "270 Tablets", "code_info": "ATORVASTATIN CALCIUM, Tablet, 80 mg has the following codes:   Pedigree: AD73627_1, EXP: 5/30/2014;  Pedigree: W003213, EXP: 6/14/2014;  Pedigree: AD46300_1, EXP: 5/15/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ATORVASTATIN CALCIUM, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378212277.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-903-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA079135"], "brand_name": ["TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE"], "generic_name": ["TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-294", "68462-329", "68462-295", "68462-296"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TRANDOLAPRIL", "VERAPAMIL HYDROCHLORIDE"], "rxcui": ["897781", "897783", "897844", "897853"], "spl_id": ["a3d55a5c-1f69-456d-a01a-60c18b186264"], "spl_set_id": ["39bad727-af4c-4d20-933b-7f287e88099a"], "package_ndc": ["68462-329-01", "68462-329-10", "68462-295-01", "68462-295-10", "68462-295-90", "68462-296-01", "68462-296-10", "68462-296-90", "68462-294-01", "68462-294-10", "68462-294-90"], "is_original_packager": [true], "upc": ["0368462295014"], "nui": ["N0000175562", "N0000000181"], "pharm_class_epc": ["Angiotensin Converting Enzyme Inhibitor [EPC]"], "pharm_class_moa": ["Angiotensin-converting Enzyme Inhibitors [MoA]"], "unii": ["V3888OEY5R", "1T0N3G9CRC"]}, "product_type": "Drugs", "event_id": "92859", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide in the U.S.", "recall_number": "D-1095-2023", "product_description": "Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01", "product_quantity": "1,200 bottles", "reason_for_recall": "Subpotent: Out of Specification for Assay Test at the 3-month time point.", "recall_initiation_date": "20230814", "center_classification_date": "20230822", "report_date": "20230830", "code_info": "Batch # 19224744"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; buPROPion HCl ER (XL), Tablet, 150 mg may be potentially mislabeled as    MESALAMINE CR, Capsule, 250 mg, NDC 54092018981, Pedigree: AD52412_1, EXP: 5/17/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "buPROPion HCl ER (XL), Tablet, 150 mg has the following code    Pedigree: AD52412_4, EXP: 4/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "buPROPion HCl ER (XL), Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 67767014130", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-722-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:  0397883    0353267    0408663    0400621      0400621", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "POTASSIUM CHLORIDE ***(30ML VIAL) 2MEQ/ML INJECTABLE\t750 MLS;  POTASSIUM CHLORIDE IN NORMAL SALINE 40MEQ/100ML (400MEQ/L) INJECTABLE\t1000 ML;  POTASSIUM CHLORIDE**(25X20ML) 2MEQ/ML  INJECTABLE\t500 ML;  POTASSIUM PHOSPHATE 4.4MEQ/ML (3MMOL/ML) INJECTABLE\t300 ML  \t  \t750 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1603-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1694-2019", "product_description": "POTASSIUM CHLORIDE 15% (2MEQ/ML) INJ SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0954-30", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Little Rock", "address_1": "7321 Cantrell Rd", "reason_for_recall": "Lack of Assurance of Sterility - the firm is recalling select sterile drug products.", "address_2": "", "product_quantity": "30,796 syringes", "code_info": "Lot: 8502 BUD: 11/21/2016, Lot: 8962 BUD: 02/21/2017", "center_classification_date": "20161213", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "Phenylephrine HCl 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL Single-Dose Syringe, Rx Only Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207, NDC 52533-171-12", "report_date": "20161221", "classification": "Class II", "openfda": {}, "recalling_firm": "Cantrell Drug Company", "recall_number": "D-0185-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "75745", "termination_date": "20200429", "more_code_info": "", "recall_initiation_date": "20161118", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1696-2019", "product_description": "PROCAINE HCL 20 MG/ML (MDV) INJECTABLE SOLUTION, 30 ML per vial.  RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0987-30", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208368"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-367", "43598-368", "43598-369"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["b6dbd55a-a71d-0cf8-2c73-7ebbfc032906"], "spl_set_id": ["0837aabc-e796-0e07-8958-71f1ff6e89bf"], "package_ndc": ["43598-367-30", "43598-367-05", "43598-368-30", "43598-368-05", "43598-369-30", "43598-369-05"], "is_original_packager": [true], "upc": ["0343598369303"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95500", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0027-2025", "product_description": "Cinacalcet Tablets, 60 mg, 30-count bottles, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India, NDC 43598-368-30.", "product_quantity": "35880 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241009", "center_classification_date": "20241028", "report_date": "20241106", "code_info": "Lot# T2200698, Exp 01/2025; T2201444, Exp 03/2025; T2202827, Exp 06/2025; T2300531, Exp 12/2025; T2301696, Exp 02/2026; T2304726, Exp 08/2026; T2400480, Exp 11/2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0994-2020", "product_description": "Zinc Chloride Injection, ZINC CHLORIDE  10MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0224-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10302019+53170, Exp 2/9/2020"}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0456-2024", "product_description": "The GOAT SUBLINGUAL STRIP, MALE ENHANCEMENT, 2 Pack, Distributed by Hombres LLC, 130 Maccormick Ave, Suite 105, Costa Mesa, A, UPC 6 61631 26363 1.", "product_quantity": "10 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0737-2019", "product_description": "Dr. King's SafeCare Rx Sleep Aid, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955263920, NDC 57955-2640-2", "product_quantity": "1244 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 022318F Exp. 02/20; 020416A Exp. 02/19; 080916N Exp. 08/19"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0852-2023", "product_description": "Trihexyphenidyl Hydrochloride Oral Solution, USP, 2mg/5mL, 473 mL bottles,  Rx only, Distributed by: VersaPharm, Inc. - An Akorn Company- Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Hurst", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70003", "recalling_firm": "Right Value Drug Stores, Inc.", "address_1": "122 Grapevine Hwy", "address_2": "N/A", "postal_code": "76054-2406", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "KS, MO, and TX.", "recall_number": "D-0335-2015", "product_description": "Glutathione 200 mg/mL Injectable, packaged in a) 5 mL MDV (multiple dose vials), b) 30 mL MDV (multiple dose vials), and c) 100 mL MDV (multiple dose vials), Rx only, Carie Boyd's Prescription Shop, 122 Grapevine Highway, Hurst, TX 76054, (817) 282-9376.", "product_quantity": "a) 26 vials, b) 15 vials, c) 16 vials", "reason_for_recall": "Incorrect Product Formulation: An incorrect gas was used to remove the oxygen from the vial.", "recall_initiation_date": "20141212", "center_classification_date": "20150108", "termination_date": "20161123", "report_date": "20150114", "code_info": "Lot #: 11142014@5, 10142014@17, 11032014@13, 08262014@6, 09162014@6, 06272014@12, 08052014@5, 07222014@18, 07222014@3,   06262014@11, 06182014@3", "more_code_info": ""}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0340-2020", "product_description": "Viatrexx-Arthros, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0030, NDC 73069-035-41.", "product_quantity": "6 vials", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00021, Exp. May: 2020"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-0991-2016", "product_description": "Hydrogen Peroxide 3%, packaged in 10mL bottles, Rx only,   Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01222016:81@52, Exp. 03/25/2016; Lot #:03042016: 23@29, Exp.05/22/2016; Lot #:03212016:35@53, Exp.    05/22/2016"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0793-2018", "product_description": "Ondansetron 8 mg tablet NDC 57237-0076-30 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71973", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0036-2016", "product_description": "Up&Up loratadine orally disintegrating tablets, USP, 10 mg, 30-count tablets per box,  Distributed by Target Corp, Minneapolis, MN  55403; NDC 11673-527-31, UPC 3 5166052731 5", "product_quantity": "34,488 boxes", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "recall_initiation_date": "20150728", "center_classification_date": "20151015", "termination_date": "20161028", "report_date": "20151021", "code_info": "Batch Numbers:  2617892, 2617893, Exp 5/31/2016; 2625092, 2625093, Exp 6/30/2016;  2658137, 2658138, Exp 11/30/2016"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DULoxetine HCl DR, Capsule, 20 mg, may be potentially mis-labeled with one of the following drugs:  ENTECAVIR, Tablet, 0.5 mg, NDC 00003161112, Pedigree: AD30140_28, EXP: 5/7/2014;  CALCIUM ACETATE, Capsule,  667 mg, NDC 00054008826, Pedigree:  AD54587_1, EXP: 5/21/2014;  FLUoxetine HCl, Capsule, 10 mg\t, NDC 16714035103, Pedigree: AD70585_13, EXP: 5/29/2014;  CHOLECALCIFEROL", "address_2": "", "product_quantity": "600 Capsules", "code_info": "DULoxetine HCl DR, Capsule, 20 mg has the following codes:    Pedigree: AD30140_31, EXP: 5/7/2014;  Pedigree: AD54587_4,  EXP: 5/21/2014;  Pedigree: AD70585_16, EXP: 5/29/2014;  Pedigree: W003506, EXP: 6/21/2014;  Pedigree: AD60272_61, EXP: 5/22/2014;  Pedigree: AD21790_49, EXP: 5/1/2014;  Pedigree: W003005, EXP: 6/11/2014;  Pedigree: W003486, EXP: 6/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DULoxetine HCl DR, Capsule, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002323560.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-766-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66210", "recalling_firm": "Avella of Deer Valley, Inc.", "address_1": "23620 N 20th Dr Ste 12", "address_2": "N/A", "postal_code": "85085-0621", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1059-2013", "product_description": "Vancomycin PF (BSS) 1%, 1 mL, Avella Specialty Pharmacy, Phoenix, AZ 85085, 877-782-7684", "product_quantity": "250 units", "reason_for_recall": "Lack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.", "recall_initiation_date": "20130909", "center_classification_date": "20130916", "termination_date": "20131017", "report_date": "20130925", "code_info": "12-20130508@181, Exp 10/4/2013", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "63 units", "code_info": "Rx #'s:   0386512    0388165    0390153    0392066    0392315    0392317    0384766          0392082    0392094    0379483    0385383      0393729          0397989      0398600      0406470    0407865    0407875    0409041    0410198    0386262    0399600      0386262    0408795    0395274    0395279    0395285    0376062      0389403    0399790    0400511      0400527    0401472      0402407    0402536      0403638    0406466    0406692    0407272    0405789    0394350      0402541        0394350        0392062    0392062", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "SERMORELIN ACETATE, LYOPHILIZED 6MG KIT\t1 KIT  \t  \t  \t  \t  \t  \t2 KIT;  \t  \t  \t  SERMORELIN ACETATE, LYOPHILIZED 6MG VIAL\t2 VIAL;  \t  SERMORELIN ACETATE, LYOPHILIZED 9MG KIT\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t3 KIT  \t  \t  \t6 KIT;  SERMORELIN ACETATE, LYOPHILIZED 9MG VIAL\t1 VIAL  \t2 VIAL  \t  \t  \t3 VIAL  \t  \t30 VIAL;  SERMORELIN ACETATE/GHRP 2,6 - LYOPHILIZED 9MG/3.15MG/3.15MG KIT\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t3 KIT;  SERMORELIN ACETATE/GHRP 2,6 - LYOPHILIZED 9MG/3.15MG/3.15MG VIAL\t1 VIAL  \t  \t  \t  \t  \t3 VIAL  \t  \t  \t4 VIAL  \t7 VIAL  (16 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1616-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0690-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0419-1.", "product_quantity": "418 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893810, Exp 04/28/2023; 37-894698, Exp 04/30/2023; 37-896144, Exp 05/06/2023; 37-897896, Exp 05/13/2023; 37-899172, Exp 05/19/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0031-2024", "product_description": "HYDROmorphone in 0.9% Sodium Chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2012-1", "product_quantity": "2,664 30 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:  17-275339, Exp. 10/3/2023; 17-275478, 17-275488, Exp. 10/4/2023; 17-275620, Exp. 10/8/2023; 17-275777, 17-275793, Exp. 10/10/2023; 17-275863, 17-275958, Exp. 10/11/2023; 17-276027, Exp. 10/16/2023; 17-275730, Exp. 10/9/2023."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-812-2015", "product_description": "Naproxen Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Libertyville", "address_1": "2401 Commerce Dr", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "address_2": "", "product_quantity": "666 bottles", "code_info": "Expiry, lot: [30-count] 2/28/2019: 7285177; 3/31/2019: 7222163, 7227175; 8/31/2019: 8162190, 8183227.  [90-count] 2/28/2019: 7207135, 7212280,  7215073; 3/31/2019: 7222162; 8/31/2019: 8095248, 8095249", "center_classification_date": "20180818", "distribution_pattern": "Nationwide USA", "state": "IL", "product_description": "Valsartan Tablets, 160 MG, 30-count bottle (NDC 54569-6583-0), 90-count bottle (NDC 54569-6583-1), Rx Only, MFG: Zhejiang Huahai Pharma, Linhai, Zhejiang 317024 China", "report_date": "20180829", "classification": "Class II", "openfda": {}, "recalling_firm": "A-S Medication Solutions LLC.", "recall_number": "D-1108-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80748", "more_code_info": "", "recall_initiation_date": "20180717", "postal_code": "60048-4464", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1010-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder, Red MD, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800", "more_code_info": ""}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1094-2016", "product_description": "All boric acid Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave Ste A", "reason_for_recall": "Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule", "address_2": "", "product_quantity": "1,416 cartons", "code_info": "Lot 150950, exp. 3/31/17 and lot 154813, exp. 5/31/2017", "center_classification_date": "20160902", "distribution_pattern": "Product was distributed in the following states: Nationwide", "state": "OH", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 15 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH ----   Carton NDC 60687-133-25; Blister NDC 60687-133-95", "report_date": "20160914", "classification": "Class II", "openfda": {}, "recalling_firm": "Amerisource Health Services", "recall_number": "D-1483-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75076", "termination_date": "20171218", "more_code_info": "", "recall_initiation_date": "20160824", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0023-2025", "product_description": "Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-079-56", "product_quantity": "1008 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000037436, exp. date 30-Oct-24 C274-000038893, exp. date 7-Jan-25", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0761-2020", "product_description": "MORPHINE 7MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@21 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81061", "recalling_firm": "Humco Holding Group, Inc", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0022-2019", "product_description": "Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-8077-43 Packaged by: Humco Texarkana, TX 75501", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.", "recall_initiation_date": "20180828", "center_classification_date": "20181012", "termination_date": "20200507", "report_date": "20181024", "code_info": "Lots: A24542 Exp. 02/2019; A25528 Exp. 04/2019; A27119 Exp. 05/2019; A27810 Exp. 06/2019"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0447-2020", "product_description": "OCuSOFT Eye Wash Sterile Isotonic Buffered Solution, 1 FL OZ (30 mL), Manufactured for OCuSOFT, Inc. Richmond, TX 77406-0429, NDC  54799-565-01", "product_quantity": "55,134 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "18026    1/21    18100    4/21        19052    2/22        19130    5/22"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "63759", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-072-2013", "product_description": "Atorvastatin Calcium Tablets, 40 mg, a) 90 tablets per bottle, b) 500 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: a)  63304-829-90, b) 63304-829-05.", "product_quantity": "157,026 Bottles", "reason_for_recall": "Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.", "recall_initiation_date": "20121109", "center_classification_date": "20121129", "termination_date": "20140428", "report_date": "20121205", "code_info": "a) 40 mg 90 count, Lot #s: 2434265, 2434266, 2434824, 2434826, 2434827, 2434828, 2434829, 2434830, 2434831, Exp 07/31/2014; 2436580, 2436725, 2436727, 2436729, 2437377, 2437380, 2437941, 2437943, 2437944, 2437949, 2437950, 2437955, Exp 08/31/2014.  b) 40 mg 500 count, Lot #s: 2437956, 2437957, 2440675, Exp 08/31/2014."}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1555-2019", "product_description": "AIR HEADS ORANGE SCENTED ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "13,068", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181126, Exp 11/25/2020; 20181127, Exp 11/26/2020"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1636-2019", "product_description": "Ascorbic Acid 500 MG/ML (Non-Corn) INJ (MDV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0975-50", "product_quantity": "N/A", "reason_for_recall": "Crystallization", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67135", "recalling_firm": "Abrams Royal Pharamacy", "address_1": "8220 Abrams Rd", "address_2": "N/A", "postal_code": "75231-1402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and to Canada", "recall_number": "D-1563-2014", "product_description": "MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX", "product_quantity": "74", "reason_for_recall": "Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis", "recall_initiation_date": "20131219", "center_classification_date": "20140825", "termination_date": "20161007", "report_date": "20140903", "code_info": "Lot number 11142013@74"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66172", "recalling_firm": "Medaus, Inc.", "address_1": "6801 Cahaba Valley Rd Ste 116", "address_2": "N/A", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1054-2013", "product_description": "NA Ascorbate 500 mg/mL, PF, 100 mL, Medaus Pharmacy 1-800-526-9183", "product_quantity": "15,500 mL", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.", "recall_initiation_date": "20130823", "center_classification_date": "20130913", "termination_date": "20140716", "report_date": "20130925", "code_info": "LOT # 130702-1, Exp 12/29/2013", "more_code_info": ""}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65851", "recalling_firm": "AbbVie Inc.", "address_1": "1401 Sheridan Rd", "address_2": "N/A", "postal_code": "60064-1803", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-901-2013", "product_description": "Mavik\u00bf trandolapril tablets 4mg, 100 count bottle, Rx only,  Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA", "product_quantity": "704 bottles", "reason_for_recall": "Labeling: Incorrect Package Insert; product packaged with outdated version of the insert", "recall_initiation_date": "20130801", "center_classification_date": "20130820", "termination_date": "20131107", "report_date": "20130828", "code_info": "Lot 22033GY"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0063-2016", "product_description": "CHORIONIC GONADOTROPIN, Injectable Solution,175 UNITS/1.5mg per syringe with Methylcobalamin, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "834 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "04292015@12, 05042015@8, 05202015@21, 06102015@25, 06242015@14, 07012015@8, 07062015@21, t03062015@15, t03122015@33, t03182015@45, t03192015@2, t04082015@14, t04082015@3, t04202015@22, t05082015@27, t05192015@29, t06022015@37, and t07152015@5."}, {"status": "Ongoing", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074453"], "brand_name": ["METOPROLOL TARTRATE"], "generic_name": ["METOPROLOL TARTRATE"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "product_ndc": ["69367-354", "69367-355"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL TARTRATE"], "rxcui": ["866511", "866514"], "spl_id": ["dfdf476e-ca66-4836-bc6e-1c8e035d95b0"], "spl_set_id": ["4d352c34-47f8-4662-9ac5-d5a32bd1660f"], "package_ndc": ["69367-354-10", "69367-354-01", "69367-355-10", "69367-355-01"], "is_original_packager": [true], "upc": ["0369367354103"], "unii": ["W5S57Y3A5L"]}, "product_type": "Drugs", "event_id": "97395", "recalling_firm": "Westminster Pharmaceuticals LLC", "address_1": "1321 Murfreesboro Pike Ste 607", "address_2": "N/A", "postal_code": "37217-2693", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0581-2025", "product_description": "Metoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-354-10", "product_quantity": "16,672 1000-count bottles", "reason_for_recall": "CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.", "recall_initiation_date": "20250806", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Batch # R55230021, R55230031, R55230041, Exp Date: 9/30/25; Batch # R55230051, R55230061, R55230071, R55230081, R55230091, R55230101, R55230111, R55230121, R55230131, R55230141, Exp Date: 10/31/2025; Batch # R55230151, Exp Date: 11/30/25; Batch # R55240011, Exp Date: 12/31/25; Batch # R55240021, R55240031, R55240041, R55240051, R55240061, Exp Date: 6/30/26; Batch # R55240071, R55240081, R55240091, R55240101, R55240111, R55240121, Exp Date: 7/31/26", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0414-2020", "product_description": "iSolutions ActivEyes Nighttime Lubricant Eye Ointment Preservative Free, Sterile, Net Wt: 3.5 g (1.8 oz), Manufactured by: Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931  NDC 59390-190-50", "product_quantity": "6,877 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "SKG 11/21 12/28/2018   TAQ 01/22 04/23/2019"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0477-2025", "product_description": "LX Bioboost Plus, (Each 1mL contains Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, Pyridoxine HCl 25 mg, Dexpanthenol 25 mg, Cyanocobalamin 1 mg, L-Arginine HCl 15 mg, L-Carnitine 15 mg, and Lidocaine 1 mg in SWFI), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "102 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot #: H227226, Exp 12/24/2025; H360175, Exp 6/2/2025; H368308, Exp 6/2/2025; Lot S360175, Exp 6/2/2025", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0942-2022", "product_description": "Olympia Vita-Complex Thiamine HCL (B1) 100 mg/mL Niacinamide (B3) 100 mg/mL Riboflavin 5 P04 (B2) 2 mg/mL Dexpanthenol (B5) 2 mg/mL Pyridoxine HCL (B6) 2 mg/mL Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0063-30.", "product_quantity": "8664 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: B24B1422, B24E1422 BUD: 8/14/2022, B24B1522 BUD: 8/15/2022, L24B15, L24C15, L24D15 BUD: 6/15/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078336"], "brand_name": ["EQUALINE ALL DAY ALLERGY", "GOOD NEIGHBOR PHARMACY ALL DAY ALLERGY", "REXALL ALL DAY ALLERGY RELIEF", "ALLERGY RELIEF", "TOPCARE ALL DAY ALLERGY"], "generic_name": ["CETIRIZINE HYDROCHLORIDE"], "manufacturer_name": ["United Natural Foods, Inc. dba UNFI", "Amerisource Bergen", "Dolgencorp, LLC", "CVS Pharmacy", "Topco Associates LLC"], "product_ndc": ["41163-458", "24385-998", "55910-699", "59779-458", "36800-458"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014678"], "spl_id": ["6e7bab3d-af1a-4b74-921d-99aca2aa0fd3", "49064fc4-3c0c-4d8f-9576-f57ad03f9cfe", "eba98b0b-bc85-4d05-8875-86b85bd462b4", "6e4597b4-d936-4449-a6d1-249b62130294", "c6979bbb-d34f-4967-9109-cfcaf89329ab"], "spl_set_id": ["491fae66-83b6-4beb-945b-39b9e4e021c5", "c568e388-60ab-47be-b362-7832b83d06ad", "4d79fb74-1895-4efe-8016-c0dd5ed10f7a", "98f3f2c6-da18-4055-81f1-962261360f9b", "f2919aad-9ed4-40b8-b233-4aec06df33ea"], "package_ndc": ["41163-458-39", "41163-458-66", "41163-458-72", "41163-458-76", "41163-458-95", "41163-458-58", "24385-998-74", "24385-998-65", "24385-998-75", "24385-998-58", "55910-699-66", "59779-458-13", "59779-458-39", "59779-458-95", "59779-458-75", "59779-458-76", "59779-458-88", "59779-458-66", "59779-458-72", "59779-458-70", "59779-458-58", "59779-458-06", "59779-458-00", "36800-458-13", "36800-458-66", "36800-458-39", "36800-458-95", "36800-458-72", "36800-458-75", "36800-458-47", "36800-458-87", "36800-458-06", "36800-458-58", "37808-458-66", "3700306594", "42507-458-66", "49738-458-66", "30142-458-66", "49781-106-14", "55316-458-66", "21130-458-66", "0363-0495-66", "46994-458-66", "41520-458-66", "41190-458-66", "0411902233", "37012-458-66", "3700306776", "55312-458-66", "0154001210"], "is_original_packager": [true], "unii": ["64O047KTOA"], "upc": ["370030659432", "041190223343", "370030677689", "015400121026"]}, "product_type": "Drugs", "event_id": "72505", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0525-2016", "product_description": "Cetirizine HCl 10 mg Tablet, 14 count blister packs, sold over the counter under the following brands, GoodSense brand distributed by Perrigo, Allegan, MI; Equaline brand distributed by; Supervalu Inc, Eden Prairie, MN (NDC 41163-458-66); Good Neighbor Pharmacy brand, distributed by AmerisourceBergen, Chesterbrook, PA (NDC 24385-998-74); HEB brand, San Antonio, TX (NDC 37808-458-66); Rexall brand Packaged for Dolgencorp LLC, Goodlettsville, TN (NDC 55910-699-66 UPC: 370030659432), HyVee brand, distributed by Hy-Vee Inc., West Des Mones, IA (NDC 42507-458-66); Smart Sense brand distributed by Kmart Corporation, Hoffman Estates, IL (NDC 49738-458-66); Kroger brand distributed by The Kroger Co, Cincinnati, OH (NDC 30142-458-66); Leader brand distributed by Cardinal Health, Dublin, OH (NDC 49781-106-14; CVS Pharmacy brand distributed by CVS Pharmacy, Inc., Woonsocket, RI (NDC 59779-458-66); Healthy Accents brand distributed by DZA Brands, LLC, Salisbury, NC (NDC 55316-458-66); Safeway Care brand distributed by Safeway Inc., Pleasanton, CA (NDC 21130-458-66); Topcare brand distributed by Topsco Associates, LLC, Skokie, IL (NDC 36800-458-66); Wal-Zyr brand distributed by Walgreens Co, Deerfield, IL (NDC 0363-0495-66); Being Well brand distributed by Save-A-Lot Food Stores, Ltd, Earth City, MO (NDC 46994-458-66); CareOne brand distributed by FoodHold, USA LLC, Landover, MD (NDC 41520-458-66); Shoprite brand distributed by Wakefern Food, Corp, Keasbey, NJ (NDC 41190-458-66 UPC: 041190223343); Shopko brand distributed by Shopko Stores Operating Co., LLC, Green Bay, WI (NDC 37012-458-66 UPC: 370030677689); Western Family brand distributed by Western Family Foods, Inc., Portland, OR (NDC 55312-458-66 UPC: 015400121026)", "product_quantity": "209,256 cartons", "reason_for_recall": "Failed Impurity/Degradations Specifications; impurity identified as cetirizine monosaccharide ester", "recall_initiation_date": "20150928", "center_classification_date": "20151224", "termination_date": "20160322", "report_date": "20151230", "code_info": "Batches: Exp 05/16:   4GE1457;  4GE1500;  4GE1819;  4GE1893;     4HE1255;  4HE1396;   4HE1620;   4HE1656;   4HE1811;     4JE1035;   4JE1212;   4JE1324;   4JE1513; and      4KE1377"}, {"status": "Terminated", "city": "Wilmington", "state": "DE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89606", "recalling_firm": "Positive Health", "address_1": "1013 Centre Rd", "address_2": "Suite 403B", "postal_code": "19805-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed nationwide via the internet through Amazon Marketplace.", "recall_number": "D-0645-2022", "product_description": "RISE UP RED EDITION Capsules, 650 mg, 10-count blisters packaged in a carton, ASIN B08JCWG84D, barcode X002NI8PE1.", "product_quantity": "5,500 cartons", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20220210", "center_classification_date": "20220304", "termination_date": "20220603", "report_date": "20220302", "code_info": "Lot # 48658908, Exp. date 09/09/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80053", "recalling_firm": "RIJ Pharmaceutical LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0843-2018", "product_description": "Preferred Plus Pharmacy Antacid (Aluminum Hydroxide 200mg, Magnesium Hydroxide 200mg Simethicone 20mg, packaged in 12 FL. OZ. (355 mL) bottles,   Manufactured By: RIJ PHARMACEUTICAL CORPORATION 40 Commercial Avenue Middletown, NY 10941, Distributed by: Kinray Inc. Whitestone, NY 11357, NDC 53807-12612, UPC 53807126122", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.", "recall_initiation_date": "20180507", "center_classification_date": "20180608", "termination_date": "20230407", "report_date": "20180620", "code_info": "Lot #: 707006,  Exp. 07/19; 708001, Exp. 08/19"}, {"country": "United States", "city": "Fajardo", "address_1": "Road 195, Km 1.1", "reason_for_recall": "Failed Impurity/Degradation Specifications due to moisture ingress in individual bottles", "address_2": "Union Street", "product_quantity": "5439 bottles", "code_info": "0.9 mg: 512348A", "center_classification_date": "20130131", "distribution_pattern": "US Nationwide", "state": "PR", "product_description": "Femtrace 0.9 mg (Estradiol Acetate) Tablets, Rx Only, 100 tablets, Manufactured by Pharmaceutics International Inc, Hunt Valley, MD 21031 for Warner Chilcott Company LLC, Fajardo, PR 00738", "report_date": "20130206", "classification": "Class III", "openfda": {}, "recalling_firm": "Warner Chilcott Company LLC", "recall_number": "D-141-12013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64014", "termination_date": "20150616", "more_code_info": "", "recall_initiation_date": "20121221", "postal_code": "00738", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0669-2022", "product_description": "Betamethasone Dipropionate Lotion USP, 0.05%* (Augmented), packaged in a) 30 mL (29 grams) bottles, NDC 52565-023-29; b) 60 mL (58 grams) bottles, NDC 52565-023-59, Rx Only, Teligent Pharma, Inc., Buena, NJ  08310", "product_quantity": "43,218 bottles", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15998, Exp. 3/31/2022; b) 16104, Exp. 4/30/2022; 16133, Exp. 5/31/2022; 16391, Exp. 8/31/2022; 15440, Exp. 9/30/2022"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ROSUVASTATIN CALCIUM, Tablet, 5 mg may have potentially been mislabeled as one of the following drugs:  IBUPROFEN, Tablet, 400 mg, NDC 67877029401, Pedigree: W002577, EXP: 6/3/2014;  ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD21846_49, EXP: 5/1/2014.", "address_2": "", "product_quantity": "180 Tablets", "code_info": "ROSUVASTATIN CALCIUM, Tablet, 5 mg has the following codes:   Pedigree: W002567, EXP: 6/3/2014;  Pedigree: AD21811_10, EXP: 5/2/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ROSUVASTATIN CALCIUM, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00310075590.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-887-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84122", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0541-2020", "product_description": "Regular Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 67751-151-01.", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191022", "center_classification_date": "20191201", "report_date": "20191211", "code_info": "all lots", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-223-2014", "product_description": "Methylprednisolone 80mg PF 1ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "2187 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA070967"], "brand_name": ["SENSORCAINE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-461", "63323-472", "63323-463", "63323-468"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE", "EPINEPHRINE BITARTRATE"], "rxcui": ["1012377", "1012384", "1012413", "1012417", "1724786", "1724787", "1724809", "1724810", "1867594", "1867596", "1867618", "1867620"], "spl_id": ["cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"], "spl_set_id": ["bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"], "package_ndc": ["63323-472-03", "63323-472-17", "63323-472-01", "63323-472-37", "63323-463-01", "63323-463-57", "63323-461-01", "63323-461-57", "63323-468-02", "63323-468-37", "63323-468-01", "63323-468-17"], "is_original_packager": [true], "upc": ["0363323472030", "0363323461010", "0363323463014", "0363323468026", "0363323472016", "0363323468019"], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "91198", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0127-2023", "product_description": "Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 125 mg per 50 mL (2.5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-461-01), packaged in 25 Multiple Dose Vials per tray (NDC 63323-461-57), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.", "product_quantity": "40,375 vials", "reason_for_recall": "Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.", "recall_initiation_date": "20221122", "center_classification_date": "20230113", "termination_date": "20231023", "report_date": "20230125", "code_info": "Batch #: 6128061, exp 03/2024; 6128663, 6128664, exp 05/2024"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078993"], "brand_name": ["LEVETIRACETAM"], "generic_name": ["LEVETIRACETAM"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-245", "65862-246", "65862-247", "65862-315"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVETIRACETAM"], "rxcui": ["311288", "311289", "311290", "387003"], "spl_id": ["61244070-03c7-41d1-a784-b46dfc93fcbc"], "spl_set_id": ["2471ee03-d747-4113-86d0-1aa93c8f3eba"], "package_ndc": ["65862-245-08", "65862-245-05", "65862-246-08", "65862-246-05", "65862-247-08", "65862-247-05", "65862-315-30", "65862-315-60", "65862-315-05"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["44YRR34555"]}, "product_type": "Drugs", "event_id": "85183", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1233-2020", "product_description": "Levetiracetam Tablets USP 750 mg 120-count bottles,  Rx Only,  Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08", "product_quantity": "8040 units", "reason_for_recall": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed", "recall_initiation_date": "20200318", "center_classification_date": "20200413", "termination_date": "20240325", "report_date": "20200422", "code_info": "Lot #: 24719001A1, Exp. Date 03/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0813-2023", "product_description": "Ketorolac Tromethamine Ophthalmic Solution, 0.5%, Sterile, packaged in a) 3mL bottles, b bottles) 5 mL, and c)10 mL bottles, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0092-2015", "product_description": "Hydroxocobalamin 5 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "25 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07232014@25, Exp 10/21/2014", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot # t01-23-2017@83, Exp 5/24/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "FERR GLUC/PROCAINE 10ML MDV 60/10MG/ML INJ, Injection, 60mg/10mg/mL, Rx only,  10 mL glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0716-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0250-2016", "product_description": "Dexamethasone Sodium Phosphate PF (10 mg/mL), 2 mL Single Use Vial, For IV or IM Use Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3227-02", "product_quantity": "235 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20151407@13 BUD: 1/10/2016"}, {"status": "Terminated", "city": "Orangeburg", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021524"], "brand_name": ["PREVANTICS MAXI SWABSTICK"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["Professional Disposables International, Inc."], "product_ndc": ["10819-4076"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["1191171", "1366736"], "spl_id": ["f5aff4be-ddc9-63ad-e053-2a95a90a426b"], "spl_set_id": ["93ca3c07-40b4-3a91-e053-2995a90a0afd"], "package_ndc": ["10819-4076-4", "10819-4076-3"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "89547", "recalling_firm": "Professional Disposables International, Inc.", "address_1": "2 Nice Pak Park", "address_2": "", "postal_code": "10962-1317", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0570-2022", "product_description": "Prevantics (chlorhexidine gluconate and isopropyl alcohol) Maxi Swabstick, 3.15% w/v and 70% v/v, packaged as a) One Maxi Swabstick, 0.172 fl. Oz. (5.1 mL) Each in a pouch, 30 Individual Maxi Swabsticks per carton, 10 boxes of 30 Individual Swabsticks per case, NDC 10819-4076-4, REORDER NO. S41950; b) One Maxi Swabstick, 0.172 fl. Oz. (5.1 mL) Each in a pouch, 300 Individual Swabsticks per case, NDC 10819-4076-3, REORDER NO. S27350; Professional Disposables International, Inc., Orangeburg, NY  10962-1376.", "product_quantity": "a) 9518 cases; b) 3347 cases", "reason_for_recall": "cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.", "recall_initiation_date": "20220204", "center_classification_date": "20220218", "termination_date": "20231031", "report_date": "20220302", "code_info": "Lot #: a) 12000315, Exp Feb 2022; 12000700, Exp Mar 2022; 12001112 LE, Exp Jun 2022; 12001214, Exp Jul 2022; 12001362, 12001406, Exp Aug 2022; 12001628, Exp Sep 2022; 12001856, Exp Oct 2022; 12002103, Exp Dec 2022; 12002113, 12100024, Exp Jan 2023; 12100226, 12100227, Exp Feb 2023; 12100443, 12100503, Exp Mar 2023; 12100516, 12100517, Exp Apr 2023; 12100748, 12100756, Exp May 2023; b) 12001113 LE, Exp Jun 2022; 12001289, 12001240, Exp Jul 2022; 12002104, Exp Dec 2022; 12100025, Exp Jan 2023; 12100405, Exp Mar 2023; 12100674, Exp Apr 2023; 12100779, Exp May 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0941-2016", "product_description": "Vancomycin 500 mg in 250 mL 0.9% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR", "product_quantity": "1 bag", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1121-2020", "product_description": "Dragon Pain Balm, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["EQUATE NASAL"], "generic_name": ["OXYMETAZOLINE HCL"], "manufacturer_name": ["Wal-Mart Stores Inc"], "product_ndc": ["49035-388"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["0b25425e-adf3-41b8-8abd-fe77a300e551"], "spl_set_id": ["c38a2783-aed9-466d-8976-59d03a792c04"], "package_ndc": ["49035-388-10", "49035-388-00", "49035-388-20"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0626-2022", "product_description": "No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY: Walmart Inc., Bentonville, AR 72716. NDC 49035-388-10", "product_quantity": "178,128 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1CK0897, 1FK1233, 1FK1232, Exp 01/31/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "68968-5552-1"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87980", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0393-2021", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDC 68968-5552-1) per box (NDC 68968-5552-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.", "product_quantity": "9,587 boxes", "reason_for_recall": "Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.", "recall_initiation_date": "20210520", "center_classification_date": "20210524", "report_date": "20210602", "code_info": "Lot: 88528 Exp. 09/2021"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0813-2022", "product_description": "RE-1, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 200 mcg/mL, Packaged in a) 10 mL Multi-Dose vial, NDC 73198-0015-10; b) 2.5 mL Multi-Dose vial, NDC 73198-0015-03;   Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835.", "product_quantity": "1849 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: a) E47B18 BUD: 5/18/2022; b) E47C18 BUD: 5/18/2022, H24G31 BUD: 8/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-972-2013", "product_description": "L-TRYPTOPHAN 300 MG/ML INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "02282013@12", "more_code_info": ""}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1527-2014", "product_description": "Vitamin B12 Cyanocobalamin with MIC Injection USP 1000 mcg/ml, packaged in 10 ml vials and 30 ml vials, Sterile, for IM or Deep SQ Use, Multiple Dose Vial,  Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "North York", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["ANDA077538"], "brand_name": ["FLUTICASONE PROPIONATE"], "generic_name": ["FLUTICASONE PROPIONATE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0829"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["FLUTICASONE PROPIONATE"], "rxcui": ["1797907"], "spl_id": ["de4b94c3-9864-33f5-8afe-ec494562de52"], "spl_set_id": ["3830675d-b45e-fc97-1f73-674b1fc38c80"], "package_ndc": ["60505-0829-1"], "is_original_packager": [true], "unii": ["O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "80202", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Dr", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0841-2018", "product_description": "Fluticasone propionate Nasal Spray, USP, 50 mcg, packaged in 50 mcg per spray 120 Metered Sprays bottles, 16 g net fill weight, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, FL 33326, NDC 60505-0829-1", "product_quantity": "Unknown", "reason_for_recall": "Presence of foreign substance: glass particles", "recall_initiation_date": "20180531", "center_classification_date": "20180606", "termination_date": "20220928", "report_date": "20180613", "code_info": "Lot: NJ4501 Exp. 07/2020"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0425-2024", "product_description": "VANCOMYCIN 1.25 g added to 0.9% Sodium Chloride 250 mL Injection, 250 mL bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0923-59, Bar Code 70004092359", "product_quantity": "368 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049049 Exp 12/28/23", "more_code_info": ""}, {"status": "Completed", "city": "Jadcherla Mandal, Mahaboob Nagar", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA203311"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-745", "31722-746", "31722-747", "31722-748"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["2b44fd7a-fd5a-984d-e063-6294a90a3fff"], "spl_set_id": ["0ff36e83-b307-42db-a2ab-bae3f6805c20"], "package_ndc": ["31722-745-30", "31722-745-90", "31722-745-05", "31722-745-31", "31722-745-32", "31722-746-30", "31722-746-90", "31722-746-05", "31722-746-31", "31722-746-32", "31722-747-30", "31722-747-90", "31722-747-05", "31722-747-31", "31722-747-32", "31722-748-30", "31722-748-90", "31722-748-05", "31722-748-31", "31722-748-32", "3317227453"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"], "upc": ["331722745307"]}, "product_type": "Drugs", "event_id": "80773", "recalling_firm": "Hetero Labs Limited Unit V", "address_1": "Unit V (SEZ Unit I in APIIC SEZ)", "address_2": "Surv. No. 439-441, 458, Polepally Vill.", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1113-2018", "product_description": "Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 40 mg, 30 Tablets Rx Only   Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854   By: Hetero Hetero Labs Limited Unit V, Polepally  Jadcherla Mahaboob Nagar - 509-301, India.   NDC 31722-745-30  UPC 331722745307", "product_quantity": "316,380 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180808", "center_classification_date": "20180823", "report_date": "20180829", "code_info": "All Lots with expiration dates 7/2018 to 6/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA021859"], "brand_name": ["HYLENEX RECOMBINANT"], "generic_name": ["HYALURONIDASE"], "manufacturer_name": ["Antares Pharma, Inc."], "product_ndc": ["18657-117"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["HYALURONIDASE (HUMAN RECOMBINANT)"], "rxcui": ["630936", "630939"], "spl_id": ["37c02d08-e964-4065-ba96-69fe8eed5c2e"], "spl_set_id": ["3023cc56-ed4b-4e87-b3a1-81b20943f658"], "package_ndc": ["18657-117-01", "18657-117-02", "18657-117-04", "1000008319", "1000008206", "1000008205"], "is_original_packager": [true], "nui": ["N0000175531", "M0009499"], "pharm_class_epc": ["Endoglycosidase [EPC]"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "unii": ["743QUY4VD8"]}, "product_type": "Drugs", "event_id": "95830", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Virgina", "recall_number": "D-0116-2025", "product_description": "Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ  NDC 18657-117-04", "product_quantity": "5 cartons/20 units each carton", "reason_for_recall": "cGMP Deviations: Temperature excursion", "recall_initiation_date": "20240911", "center_classification_date": "20241210", "termination_date": "20250820", "report_date": "20241218", "code_info": "Serial # 100000831961 100000820688 100000820689 100000820515", "more_code_info": ""}, {"status": "Terminated", "city": "Jadcherla Mandal, Mahaboob Nagar", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA205166"], "brand_name": ["VALGANCICLOVIR"], "generic_name": ["VALGANCICLOVIR"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-832"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALGANCICLOVIR HYDROCHLORIDE"], "rxcui": ["313566"], "spl_id": ["2b44d151-5b10-9250-e063-6294a90a53c2"], "spl_set_id": ["383e8810-b877-4a4f-abdf-c8c4c8e394f8"], "package_ndc": ["31722-832-60", "31722-832-31", "31722-832-32"], "is_original_packager": [true], "upc": ["0331722832601"], "unii": ["4P3T9QF9NZ"]}, "product_type": "Drugs", "event_id": "79142", "recalling_firm": "Hetero Labs Limited Unit V", "address_1": "Unit V (SEZ Unit I in APIIC SEZ)", "address_2": "Surv. No. 439-441, 458, Polepally Vill.", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ and then distributed Nationwide in the USA", "recall_number": "D-0601-2018", "product_description": "Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only,   Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60", "product_quantity": "1764 60-count bottles", "reason_for_recall": "Temperature Abuse: Valganciclovir Tablets USP 450 mg and  Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).", "recall_initiation_date": "20180213", "center_classification_date": "20180316", "termination_date": "20210218", "report_date": "20180321", "code_info": "Lot #s VGC17040 & VGC17041, EXP 07/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91952", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0525-2023", "product_description": "Simvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9); b) 60-count bottle (NDC 68788-9868-6); c) 30-count bottle (NDC 68788-9868-3), Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703.", "product_quantity": "a) 88 Bottles, b) 3 Bottles, c) 175 Bottles", "reason_for_recall": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.", "recall_initiation_date": "20230323", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "a) Lot: B0922G, Exp. Date: 5/31/2023, F0322G, Exp. Date: 7/25/2024, H2622M, Exp. Date: 8/31/2024, J1422B, K0722G, Exp. Date: 10/31/2024, L1922A, Exp. Date: 2/28/2025; b) Lot: F2922S, Exp. Date: 8/31/2023, H0322G Exp. Date: 7/31/2023; c) Lot: A1322I, Exp. Date: 3/31/2023, H1122C, Exp. Date: 8/31/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87348", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0306-2021", "product_description": "Methacholine Challenge 5-Syringe Test Kits, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Dolchester, VT 06448  NDC # 05446-1600-05", "product_quantity": "213 kits", "reason_for_recall": "Temperature Abuse; labeled with the incorrect room temperature (15-25 \u00bfC) storage conditions rather than the correct refrigerated (2 - 8 \u00bfC) storage conditions", "recall_initiation_date": "20210217", "center_classification_date": "20210318", "termination_date": "20210610", "report_date": "20210324", "code_info": "Lot # 12-2020-16@10, BUD 3-30-21   Lot # 11-2020-18@11, BUD 3-02-21"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ERYTHROMYCIN DR EC Tablet, 250 mg may be potentially mislabeled as    methylPREDNISolone, Tablet, 4 mg, NDC 00781502201, Pedigree: AD46426_10, EXP: 5/15/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ERYTHROMYCIN DR EC Tablet, 250 mg has the following code    Pedigree: AD46426_13, EXP: 5/15/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ERYTHROMYCIN DR EC Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 24338012213", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-536-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0196-2025", "product_description": "Acetaminophen Extra Strength 500 mg, 1000 Tablets per bottle, Akron Pharma, Manufactured for:  Akron Pharma Inc., 373 US RT 46 W Building E, Suite 117, Fairfield, NJ 07034, NDC 71399-8022-02", "product_quantity": "1232 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot #s: KDT0224001B, Exp 08/31/2026; KDT0224002B, Exp 09/30/2026.", "more_code_info": ""}, {"country": "United States", "city": "Philadelphia", "address_1": "1100 Orthodox St", "reason_for_recall": "Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice.  Specifically, the labeling should read \"If a severely depressed HDL-C level is detected, fibrate therapy should be withdrawn, and the HDL-C level monitored until it has returned to baseline, and fibrate therapy should not be re-initiated.\"  The labeling for the recalled lots", "address_2": "", "product_quantity": "", "code_info": "Lot 6561703, exp. 03/14", "center_classification_date": "20140106", "distribution_pattern": "Nationwide and  Puerto Rico.", "state": "PA", "product_description": "Fenofibric Acid, immediate release tablet, 35 mg, 30 count bottle Rx only, Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA NDC  53489-677-07", "report_date": "20140115", "classification": "Class III", "openfda": {}, "recalling_firm": "Mutual Pharmaceutical Company,  Inc.", "recall_number": "D-399-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64727", "termination_date": "20140401", "more_code_info": "", "recall_initiation_date": "20130227", "postal_code": "19124-3168", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Manalapan", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89554", "recalling_firm": "Tsm Brands LLC", "address_1": "540 Equinox Ln", "address_2": "", "postal_code": "07726-8877", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0635-2022", "product_description": "70% Isopropyl Alcohol First Aid Antiseptic with Wintergreen, 12 FL. OZ. 355 ML bottle, Distributed By: TSM Brands LLC, 540 Equinox LN, Manalapan, NJ 07726, www.tsmbrands.com, Made in Turkey, UPC 868275965765", "product_quantity": "1.186.800 bottles", "reason_for_recall": "Labeling - product contains undeclared ethyl alcohol", "recall_initiation_date": "20220207", "center_classification_date": "20220225", "report_date": "20220309", "code_info": "Lot#: 39,40,41,42,43,44 and 45", "more_code_info": ""}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1419-2020", "product_description": "D-Biotin 300 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "390 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-07-2020:12@6, BUD 7/5/2020  01-23-2020:00@6, BUD 7/21/2020"}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0548-2022", "product_description": "APAP 325 mg (Acetaminophen 325 mg, Pamabrom 25 mg tablet) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY  NDC 62959-700-00", "product_quantity": "6,380,282 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: M700LA  Bulk Lots: 18K037, 18L093, 18M006, 19A121, 19G044, 19G045, 19G046"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "66 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03092015@11, 6/7/2015; 03302015@7, 6/28/2015; 4242015@50, 7/23/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 20 mg/ml + Clonidine 500 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1590-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "A5011 Exp 7/10/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-789-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1005-2022", "product_description": "Olanzapine single dose vial Lyophilized, 10 mg, Rx only, MFG: Auromedics Pharma LLC, NDC# 55150-0308-01", "product_quantity": "2 cartons/2 single dose vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0282-2018", "product_description": "Medline Staple Remover Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Northfield, IL 60060", "product_quantity": "248 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDR1067; Lots: 17PB4605  Pack Number: DYNDR1067H; Lots: 17PB4605", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-897-2015", "product_description": "Sodium Dichloroacetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216957"], "brand_name": ["CLINDAMYCIN HYDROCHLORIDE"], "generic_name": ["CLINDAMYCIN HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-142", "68462-143", "68462-144"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLINDAMYCIN HYDROCHLORIDE"], "rxcui": ["197518", "284215", "309329"], "spl_id": ["b56e38e4-da91-4433-a18c-a35ce9c5c465"], "spl_set_id": ["8e66de7a-d9d4-4562-bc99-80489d482da4"], "package_ndc": ["68462-142-01", "68462-143-01", "68462-143-05", "68462-144-01", "68462-144-81"], "is_original_packager": [true], "upc": ["0368462142011"], "unii": ["T20OQ1YN1W"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0344-2025", "product_description": "Clindamycin Hydrochloride Capsules, USP, 300mg, 100-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-144-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17241278, exp. date Jul-26 17241297, exp. date Jul-26 17241304, exp. date Jul-26 17241315, exp. date Jul-26 17241327, exp. date Jul-26"}]